tailieuchung - Triple negative breast cancer and platinumbased systemic treatment: A meta-analysis and systematic review

Đang chuẩn bị liên kết để tải về tài liệu:
Triple negative breast cancer and platinumbased systemic treatment: A meta-analysis and systematic review

Nhật Quốc 91 9 pdf

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ Tải xuống

Triple negative breast cancer (TNBC) represents 15–20% of breast cancers. Due to its heterogeneity and high rates of relapse, there is a need to optimize treatment efficacy. Platinum chemotherapy is still controversial and currently not recommended as first-line treatment for TNBC. | Triple negative breast cancer and platinumbased systemic treatment A meta-analysis and systematic review

Đang chuẩn bị liên kết để tải về tài liệu:
Triple negative breast cancer and platinumbased systemic treatment: A meta-analysis and systematic review

Outcome disparities in African American women with triple negative breast cancer: A comparison of epidemiological and molecular factors between African American and Caucasian women with triple negative breast cancer

AJCC 8th edition prognostic staging provides no better discriminatory ability in prognosis than anatomical staging in triple negative breast cancer

The expression of Dicer and Drosha in matched normal tissues, tumours and lymph node metastases in triple negative breast cancer

Incidence, pattern and prognosis of brain metastases in patients with metastatic triple negative breast cancer

ΔNp63α expression induces loss of cell adhesion in triple-negative breast cancer cells

CREB3L1 as a potential biomarker predicting response of triple negative breast cancer to doxorubicin-based chemotherapy

BC200 overexpression contributes to luminal and triple negative breast cancer pathogenesis

Prevalence of pathogenic BRCA1/2 germline mutations among 802 women with unilateral triple-negative breast cancer without family cancer history

ANGPTL4 overexpression inhibits tumor cell adhesion and migration and predicts favorable prognosis of triple-negative breast cancer

Breast cancer PAM50 signature: Correlation and concordance between RNA-Seq and digital multiplexed gene expression technologies in a triple negative breast cancer series

Đang chuẩn bị liên kết để tải về tài liệu: Triple negative breast cancer and platinumbased systemic treatment: A meta-analysis and systematic review